Hypercholesterolemia News and Research

RSS
Hypercholesterolemia is a condition characterized by very high levels of cholesterol in the blood. Cholesterol is a waxy, fat-like substance that is produced in the body and obtained from foods that come from animals (particularly egg yolks, meat, poultry, fish, and dairy products). The body needs this substance to build cell membranes, make certain hormones, and produce compounds that aid in fat digestion. Too much cholesterol, however, increases a person's risk of developing heart disease.

People with hypercholesterolemia have a high risk of developing a form of heart disease called coronary artery disease. This condition occurs when excess cholesterol in the bloodstream is deposited in the walls of blood vessels, particularly in the arteries that supply blood to the heart (coronary arteries). The abnormal buildup of cholesterol forms clumps (plaque) that narrow and harden artery walls. As the clumps get bigger, they can clog the arteries and restrict the flow of blood to the heart. The buildup of plaque in coronary arteries causes a form of chest pain called angina and greatly increases a person's risk of having a heart attack.

Inherited forms of hypercholesterolemia can also cause health problems related to the buildup of excess cholesterol in other tissues. If cholesterol accumulates in tendons, it causes characteristic growths called tendon xanthomas. These growths most often affect the Achilles tendons and tendons in the hands and fingers. Yellowish cholesterol deposits under the skin of the eyelids are known as xanthelasmata. Cholesterol can also accumulate at the edges of the clear, front surface of the eye (the cornea), leading to a gray-colored ring called an arcus cornealis.
Alnylam Pharmaceuticals presents ALN-VSP Phase I data for liver cancer at Chemotherapy Foundation Symposium

Alnylam Pharmaceuticals presents ALN-VSP Phase I data for liver cancer at Chemotherapy Foundation Symposium

Study demonstrates preventive effect of urate lowering therapy on cardiovascular mortality

Study demonstrates preventive effect of urate lowering therapy on cardiovascular mortality

Amgen wins Scrip Best New Drug award for Prolia

Amgen wins Scrip Best New Drug award for Prolia

Alnylam third quarter revenue increases from $24.2 million to $27.7 million

Alnylam third quarter revenue increases from $24.2 million to $27.7 million

Aegerion underwriters exercise over-allotment option

Aegerion underwriters exercise over-allotment option

Alnylam to present data on RNAi therapeutics for fibrotic diseases at The Liver Meeting

Alnylam to present data on RNAi therapeutics for fibrotic diseases at The Liver Meeting

New gene therapy product reduces plasma cholesterol levels

New gene therapy product reduces plasma cholesterol levels

Aegerion prices initial public offering of common stock

Aegerion prices initial public offering of common stock

Genzyme third quarter revenue increases to $1.0 billion

Genzyme third quarter revenue increases to $1.0 billion

Tocotrienols can help reduce triglyceride levels

Tocotrienols can help reduce triglyceride levels

Aegerion Pharmaceuticals’ MTP-I Phase III trial published in Atherosclerosis online supplement

Aegerion Pharmaceuticals’ MTP-I Phase III trial published in Atherosclerosis online supplement

USFDA grants Sun Pharma subsidiary tentative approval for generic Crestor ANDA

USFDA grants Sun Pharma subsidiary tentative approval for generic Crestor ANDA

Alnylam Pharmaceuticals publishes ALN-RSV01 Phase IIa study results

Alnylam Pharmaceuticals publishes ALN-RSV01 Phase IIa study results

Astellas Pharma announces Phase IV study results of Lexiscan injection at ASNC session

Astellas Pharma announces Phase IV study results of Lexiscan injection at ASNC session

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

High dose peretinoin reduces recurrence of HCC after surgical resection or ablation in HCV positive patients

High dose peretinoin reduces recurrence of HCC after surgical resection or ablation in HCV positive patients

Mipomersen Phase 3 trial in heFH meets primary, secondary and tertiary endpoints

Mipomersen Phase 3 trial in heFH meets primary, secondary and tertiary endpoints

Lack of preparation for winter sports, high altitudes and low temperatures trigger acute myocardial infarction

Lack of preparation for winter sports, high altitudes and low temperatures trigger acute myocardial infarction

Moderate consumption of coffee benefits aortic distensibility in hypertensive elderly individuals

Moderate consumption of coffee benefits aortic distensibility in hypertensive elderly individuals

Patients with atherothrombosis are at increased risk of ischemic events: Study

Patients with atherothrombosis are at increased risk of ischemic events: Study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.